Understanding how chemical changes in proteins affect heart cell development
Dissecting a post-translational modification code in cardiac reprogramming
This study is looking at how certain chemical changes in proteins and DNA can help heart cells change their roles and potentially heal damaged heart tissue, which could be really helpful for people with heart problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11092093 on NIH RePORTER |
What this research studies
This research investigates how post-translational modifications (PTMs) of proteins and chromatin influence the ability of heart cells to change their function and identity. By examining the roles of various chemical modifications, such as acetylation and phosphorylation, the study aims to uncover how these changes can guide heart cell differentiation and reprogramming. The approach involves detailed analysis of both histones and free proteins to understand their interactions and effects on cardiac cell fate. This could lead to new strategies for repairing damaged heart tissue.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with heart conditions, particularly those who have experienced cardiac infarction or other forms of heart damage.
Not a fit: Patients with stable heart conditions or those who do not have any cardiac issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide new insights into heart repair mechanisms, potentially leading to innovative treatments for heart diseases.
How similar studies have performed: Previous research has shown promising results in understanding the role of post-translational modifications in other cell types, suggesting potential for success in cardiac applications.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Wang, Zhong — University of Michigan at Ann Arbor
- Study coordinator: Wang, Zhong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.